Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Phase I/II Trial of Palbociclib, Pembrolizumab and Letrozole in Patients With Hormone Receptor-Positive Metastatic Breast CancerEur. J. Cancer 2021 Jul 01;154(xx)11-20, Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, S Padam, A Tang, N Martinez, D Schmolze, C Presant, B Ebrahimi, C Yeon, M Sedrak, N Patel, J Portnow, P Lee, J Mortimer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.